Increased natural killer cells and decreased CD3⁺CD8⁺CD62L⁺ T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib

Details 詳細情報について

• CRID

  1360567185515059840

• DOI

  10.1111/j.1365-2141.2011.08939.x

• ISSN

  13652141

  00071048

• Web Site

  https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.2011.08939.x

  https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2141.2011.08939.x

• Data Source

  • Crossref
  • KAKEN